Opportunity Information: Apply for RFA DK 13 020
Apply for RFA DK 13 020
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "George M. OBrien Urology Cooperative Research Centers Program (U54)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Nov 18, 2013 and posted on Nov 18, 2013.
- Applicants must submit their applications by Mar 18, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Small businesses Public housing authorities/Indian housing authorities For profit organizations other than small businesses City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The George M. O'Brien Urology Cooperative Research Centers Program (U54) is a National Institutes of Health (NIH) funding opportunity issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support a network of cooperative research centers focused on benign urologic diseases and disorders. The central idea is to build and sustain a coordinated, multidisciplinary platform where basic scientists and clinical investigators work side by side to better understand how these non-cancer urologic conditions start, develop, and progress, and then use that knowledge to create improved diagnostics, treatments, and prevention strategies that align with NIDDK mission priorities. Rather than supporting isolated projects, the program is designed to strengthen collaboration, communication, and shared scientific direction across participating groups so that discoveries can move more efficiently from mechanisms to clinical impact.
This opportunity uses the NIH Cooperative Agreement mechanism (U54), which signals a more hands-on partnership between awardees and the NIH compared with standard grant mechanisms. Applicants are expected to be willing to work cooperatively with NIDDK and with other funded centers, helping facilitate collaborations and scientific interactions not only within their own center but also among centers and with the broader research community. In practical terms, that emphasis means the program values coordinated planning, shared resources or approaches where appropriate, and active participation in network-level activities intended to raise the overall quality, reach, and efficiency of benign urology research.
A major program goal, alongside the scientific mission, is workforce development in benign urology. The centers are expected to function as a national resource for the career development of junior scientists who want to build research careers in this area. The intent is to create an environment where early-career investigators can access mentorship, collaborative projects, and research infrastructure that make it easier to establish themselves and remain in the field. This career development focus is positioned as an integral part of the center concept, not a minor add-on, reflecting the program's aim to strengthen the pipeline of investigators capable of advancing benign urologic research over the long term.
Administratively, the funding opportunity is identified as RFA-DK-13-020 and was posted on November 18, 2013, with an application closing date of March 18, 2014 (and an archive date of April 18, 2014). The total estimated funding amount listed is $3,000,000, with an award ceiling of $1,000,000, and there is no cost-sharing or matching requirement. The Catalog of Federal Domestic Assistance (CFDA) listing associated with the announcement is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). While the activity category in the source data is labeled under a broader health-related category, the program itself is clearly targeted to benign urologic diseases and disorders within NIDDK's scope.
Eligibility is broad across many U.S.-based organization types, including public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (including small businesses), and various government entities (state, county, city/township, special district governments), as well as public housing authorities/Indian housing authorities. The announcement also explicitly includes multiple types of mission- or population-focused institutions and organizations as eligible, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and certain regional organizations. Foreign institutions (non-U.S. entities) are not eligible to apply, but non-domestic components of U.S. organizations may participate, and foreign components (as defined by NIH policy) are allowed, which can enable specific international collaborations when justified and compliant with NIH requirements.
Overall, this FOA is structured to create a connected set of research hubs that push benign urology forward through team science, shared problem-solving, and active coordination with NIDDK. The program is not just about producing individual research results; it is meant to elevate the field by building durable collaborative infrastructure, encouraging cross-center interaction, and developing new investigators, with the broader outcome of improving how benign urologic disorders are understood, diagnosed, treated, and prevented.
Frequently Asked Questions (FAQs)
What is the George M. O'Brien Urology Cooperative Research Centers Program (U54)?
It is an NIH funding opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support a network of cooperative research centers focused on benign (non-cancer) urologic diseases and disorders. The program is designed to build and sustain coordinated, multidisciplinary centers where basic scientists and clinical investigators work together to improve understanding, diagnosis, treatment, and prevention of these conditions.
Which NIH Institute is sponsoring this program?
The program is issued by NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), part of the National Institutes of Health (NIH).
What is the main scientific focus of this funding opportunity?
The focus is benign urologic diseases and disorders (non-cancer urology). Centers are expected to work on understanding how these conditions start, develop, and progress, and to translate that knowledge into improved diagnostics, treatments, and prevention strategies aligned with NIDDK mission priorities.
How is this program different from funding isolated individual projects?
This program emphasizes a coordinated network model rather than stand-alone projects. It is intended to strengthen collaboration, communication, shared scientific direction, and cross-center interaction so discoveries can move more efficiently from understanding mechanisms to achieving clinical impact.
What does the U54 Cooperative Agreement mechanism mean for applicants?
The U54 Cooperative Agreement indicates a more hands-on partnership between NIH/NIDDK and awardees compared with standard grant mechanisms. Applicants are expected to be willing to work cooperatively with NIDDK and with other funded centers, including participating in network-level activities and facilitating collaborations within and across centers.
What kinds of collaboration expectations are described in the opportunity?
The opportunity highlights coordinated planning, strong communication, shared resources or approaches where appropriate, and active participation in network-level activities. Awardees are expected to help facilitate scientific interactions within their own center, among centers, and with the broader research community.
Does the program include career development or workforce development?
Yes. Workforce development in benign urology is described as a major program goal. Centers are expected to function as a national resource for career development of junior scientists, providing an environment with mentorship, collaborative projects, and research infrastructure to support early-career investigators building long-term research careers in benign urology.
Is the career development component optional or central to the program?
It is presented as integral to the center concept rather than a minor add-on, reflecting the program's intent to strengthen the pipeline of investigators in benign urologic research over the long term.
What is the funding opportunity number (FOA identifier)?
The FOA is identified as RFA-DK-13-020.
When was the FOA posted and what are the key dates?
The FOA was posted on November 18, 2013. The application closing date was March 18, 2014, and the archive date was April 18, 2014.
How much total funding is estimated for this opportunity?
The total estimated funding amount listed is $3,000,000.
What is the maximum award amount (award ceiling)?
The award ceiling listed is $1,000,000.
Is there a cost-sharing or matching requirement?
No. The opportunity states there is no cost-sharing or matching requirement.
What CFDA number is associated with this program?
The CFDA listing associated with the announcement is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
What types of organizations are eligible to apply?
Eligibility is broad across many U.S.-based organization types, including public and private institutions of higher education; nonprofits (including 501(c)(3) and non-501(c)(3) organizations); for-profit organizations (including small businesses); and various government entities (state, county, city/township, special district governments), as well as public housing authorities/Indian housing authorities.
Are minority-serving and mission-focused institutions included as eligible applicants?
Yes. The announcement explicitly includes, among eligible applicants, Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also includes faith-based or community-based organizations and certain regional organizations.
Can foreign (non-U.S.) institutions apply directly?
No. Foreign institutions (non-U.S. entities) are not eligible to apply.
Can international components still be part of a project under this FOA?
Yes, with limitations described in the opportunity. Non-domestic components of U.S. organizations may participate, and foreign components (as defined by NIH policy) are allowed, which can support specific international collaborations when justified and compliant with NIH requirements.
What is the overall purpose of building a network of centers for benign urology?
The FOA is structured to create connected research hubs that advance benign urology through team science, shared problem-solving, durable collaborative infrastructure, and active coordination with NIDDK. The intended outcome is improved understanding, diagnosis, treatment, and prevention of benign urologic disorders, while also developing new investigators in the field.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: ATSDRs Program to Promote Localized Efforts To Reduce Environmental Exposure (APPLETREE)
Previous opportunity: Water Conservation Field Services Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 13 020
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 13 020) also looked into and applied for these:
| Funding Opportunity |
|---|
| Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006 Funding Number: PAR 14 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $75,000 |
| Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas (SBIR) (R43/R44) Apply for RFA DK 13 028 Funding Number: RFA DK 13 028 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to NIDDK (STTR (R41/R42)) Apply for PA 14 054 Funding Number: PA 14 054 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (SBIR (R43/R44)) Apply for PA 14 055 Funding Number: PA 14 055 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) STTR (R41/R42) Apply for PA 14 059 Funding Number: PA 14 059 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Innovation Research (SBIR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) (SBIR (R43/R44)) Apply for PA 14 058 Funding Number: PA 14 058 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Research Using Subjects From Selected Type I Diabetes Clinical Studies (Living Biobank) (DP3) Apply for PAR 14 064 Funding Number: PAR 14 064 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) Apply for PAR 14 065 Funding Number: PAR 14 065 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Cystic Fibrosis Research and Translation Core Center (P30) Apply for RFA DK 13 007 Funding Number: RFA DK 13 007 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Systems for Health Apply for RFA 641 14 00002 Funding Number: RFA 641 14 00002 Agency: Ghana USAID Accra Category: Food and Nutrition Health Funding Amount: $68,000,000 |
| Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01) Apply for RFA DK 14 501 Funding Number: RFA DK 14 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $400,000 |
| Limited Competition Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01) Apply for RFA DK 14 502 Funding Number: RFA DK 14 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $10,000,000 |
| Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 003 Funding Number: RFA DK 14 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| Limited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 503 Funding Number: RFA DK 14 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $2,500,000 |
| Reagents for Glucagon and Incretin Research (R41/R42) Apply for PA 14 204 Funding Number: PA 14 204 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Reagents for Glucagon and Incretin Research (R43/R44) Apply for RFA DK 14 008 Funding Number: RFA DK 14 008 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Diabetes Impact Award Closed Loop Technologies Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3) Apply for RFA DK 14 014 Funding Number: RFA DK 14 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Diabetes Impact Award Closed Loop Technologies Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3) Apply for RFA DK 14 015 Funding Number: RFA DK 14 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Nutrition Obesity Research Centers (NORCs) (P30) Apply for RFA DK 14 002 Funding Number: RFA DK 14 002 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 14 012 Funding Number: RFA DK 14 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 13 020", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
